Cita APA

Owusu-Brackett, N., Evans, K. W., Akcakanat, A., Yuca, E., Tapia, C., Rizvi, Y. Q., . . . Meric-Bernstam, F. (2019). TAK228 enhances antitumor activity of eribulin in triple negative breast cancer. Oncotarget.

Citación estilo Chicago

Owusu-Brackett, Nicci, Kurt W. Evans, Argun Akcakanat, Erkan Yuca, Coya Tapia, Yasmeen Qamar Rizvi, Ecaterina Ileana Dumbrava, Filip Janku, y Funda Meric-Bernstam. "TAK228 Enhances Antitumor Activity of Eribulin in Triple Negative Breast Cancer." Oncotarget 2019.

Cita MLA

Owusu-Brackett, Nicci, et al. "TAK228 Enhances Antitumor Activity of Eribulin in Triple Negative Breast Cancer." Oncotarget 2019.